Azurity Pharmaceuticals


CutisPharma, Inc. is a privately held, specialty pharmaceutical company focusing on the development and commercialization of value added proprietary drug products and technologies for use in the pharmaceutical industry prescription compounding sector. Product line and development efforts are focused on providing standardized alternatives for a strategic segment of the preparation of 20 million currently compounded prescriptions by offering FIRST Unit-of-Use Prescription Compounding Kits.

Exhibitor Level: 
Bronze Level
Booth Number: 
Exhibitor Type: